Tag: nasdaq:abus
December 8, 2019
5 Top NASDAQ Biotech and Pharma Stocks: Atreca Climbs 45 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 3, 2019
5 Top NASDAQ Biotech and Pharma Stocks: IVERIC Up 350 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
June 23, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: Melinta Leads
Which companies were last week's top gainers? We break down the five top NASDAQ biotech and pharma stocks of the...
June 20, 2019
Arbutus Biopharma Gets Green Light for Phase 1a/1b Clinical Trial
Shares of the company spiked nearly 40 percent following the announcement it can begin its Phase 1a/1b clinical trial of...
September 9, 2018
5 Top Weekly NASDAQ Biotech Stocks: MannKind Soars 83 Percent
MannKind, Evofem Biosciences, Arbutus Biopharma, Infinity Pharmaceuticals and VBI Vaccines were last week's top gainers on the NASDAQ Biotechnology Index.
August 13, 2018
Alnylam Pharma Receives FDA Approval for Onpattro
On Friday, Alnylam Pharmaceuticals received US Food and Drug Administration approval for Onpattro (patisiran). August 13, 2018